Skip to main content
Year archive

IMUGENE LIMITED — 2019 filings

All 69 regulatory filings released by IMUGENE LIMITED (IMU) in 2019, sourced directly from the official regulator.

69 Filings
2019 Period
2019 filings (69)
Filing Released Lang
Completion of Less Than Marketable Parcel Sale 1 pa
Transaction in Own Shares
2019-12-23 English
Appendix 3B and Required LR 3.10.5A Information 15 pages 559.8KB
Capital/Financing Update
2019-12-05 English
Imugene appoints Dr R Auer to Oncolytic Virotherapy SAB 3 pages 162.3KB
Board/Management Information
2019-12-04 English
Imugene Share Placement to raise $24.6 million 2 pages 140.9KB
Capital/Financing Update
2019-12-01 English
Investor Presentation 31 pages 3.2MB
Investor Presentation
2019-12-01 English
Prospectus 39 pages 574.0KB
Capital/Financing Update
2019-12-01 English
Appendix 3B and 708A Notice 15 pages 514.4KB
Capital/Financing Update
2019-11-27 English
Trading Halt 2 pages 370.1KB
Capital/Financing Update
2019-11-27 English
Change of Director's Interest Notice - PH 2 pages 208.4KB
Director's Dealing
2019-11-27 English
Change of Director's Interest Notice - CW 2 pages 176.2KB
Director's Dealing
2019-11-26 English
CF33 Oncolytic Virus GMP Manufacturing Update 2 pages 84.5KB
Capital/Financing Update
2019-11-24 English
Imugene appoints Prof Prasad S Adusumilli of MSKCC to OV SAB 3 pages 129.8KB
Board/Management Information
2019-11-19 English
Change of Director's Interest Notice - AH 2 pages 174.2KB
Director's Dealing
2019-11-18 English
Change of Director's Interest Notice - CW 2 pages 176.1KB
Director's Dealing
2019-11-18 English
Change of Director's Interest Notice - LR 2 pages 174.2KB
Director's Dealing
2019-11-18 English
Change of Director's Interest Notice - JE 2 pages 173.9KB
Director's Dealing
2019-11-18 English
Results of Meeting - Oncolytic Virus Acquisition Complete 1
Declaration of Voting Results & Voting Rights Announcements
2019-11-17 English
Appendix 3B 13 pages 369.3KB
Capital/Financing Update
2019-11-14 English
Imugene Extraordinary General Meeting Call Details 2 pages 107.8KB
Regulatory Filings
2019-11-10 English
AGM Presentation 10 pages 2.6MB
AGM Information
2019-11-07 English
Results of Meeting 1 page 185.4KB
Declaration of Voting Results & Voting Rights Announcements
2019-11-07 English
Imugene Annual General Meeting Call Details 2 pages 107.8KB
AGM Information
2019-11-06 English
Investor Presentation - November 2019 40 pages 6.2MB
Investor Presentation
2019-11-05 English
Imugene Receives $4.13 million R&D Tax Incentive 2 pages 107.2KB
Capital/Financing Update
2019-11-03 English
Appendix 4C - quarterly 7 pages 379.0KB
Interim / Quarterly Report
2019-10-24 English
US Defense Grant to Study Imugene CF33 Oncolytic Virotherapy 3 pages 247.7KB
Regulatory Filings
2019-10-22 English
CF33 Oncolytic Virus Clinical Trial Program Update 3 pages 87.4KB
Regulatory Filings
2019-10-20 English
Change of Director's Interest Notice - AH 4 pages 279.7KB
Director's Dealing
2019-10-20 English
Appendix 3B and 708A Notice 14 pages 500.1KB
Share Issue/Capital Change
2019-10-17 English
Yuman Fong, MD to Chair Imugene Oncolytic Virotherapy SAB 3 pages 134.7KB
Board/Management Information
2019-10-16 English
Notice of Extraordinary General Meeting/Proxy Form 89 pages 1.9MB
Proxy Solicitation & Information Statement
2019-10-13 English
Notice of UMP Facility to Eligible Shareholders 1 p
Share Issue/Capital Change
2019-10-08 English
Notice of Annual General Meeting/Proxy Form 41 pages 796.5KB
AGM Information
2019-10-03 English
Share Sale Facility for Holders of Unmarketable Parcels 8 pages 1.1MB
Capital/Financing Update
2019-10-03 English
Comprehensive Phase Ib HER-Vaxx Results Presented at ESMO 2 pages 156.2KB
Regulatory Filings
2019-09-30 English
Imugene Cancer Vaccine Combinations Presented at ESMO 3 pages 160.8KB
Regulatory Filings
2019-09-30 English
Appendix 4E & Annual Report to shareholders 87 pages 5.5MB
Annual Report
2019-08-29 English
Corporate Governance Statement 6 pages 199.4KB
Governance Information
2019-08-29 English
Appendix 4G 11 pages 210.4KB
Governance Information
2019-08-29 English
2019 Bioshares Presentation 25 pages 6.8MB
Investor Presentation
2019-07-25 English
Appendix 4C - quarterly 7 pages 255.7KB
Interim / Quarterly Report
2019-07-25 English
Imugene Enhances Portfolio with Compelling Oncolytic Virus 4 pages 85.1KB
Capital/Financing Update
2019-07-14 English
Investor Presentation - Proposed Acquisition 35 pages 7.4MB
Investor Presentation
2019-07-14 English
Investor update call details 2 pages 316.2KB
Regulatory Filings
2019-07-14 English
New HER-Vaxx Cancer Vaccine trial data presented at ESMO GI 2 pages 79.5KB
Regulatory Filings
2019-07-07 English
Appendix 3B and 708A Notice 15 pages 507.5KB
Capital/Financing Update
2019-06-26 English
Updated Phase 1b HER-Vaxx data presented at ASCO 2 pages 143.2KB
Regulatory Filings
2019-06-03 English
Global Biotechnology & VC Executive Joins Imugene Board 2 pages 106.7KB
Board/Management Information
2019-05-19 English
Initial Director's Interest Notice - JE 2 pages 198.4KB
Director's Dealing
2019-05-19 English
Investor Presentation 34 pages 5.6MB
Investor Presentation
2019-04-30 English
New Cancer Vaccine Trial Data presented at ASCO 2019 2 pages 76.0KB
Regulatory Filings
2019-04-28 English
Leading Global Pharmaceutical Executive Joins Imugene Board 2 pages 101.8KB
Board/Management Information
2019-04-22 English
Initial Director's Interest Notice - LR 2 pages 196.6KB
Director's Dealing
2019-04-22 English
Investor Presentation 27 pages 6.5MB
Investor Presentation
2019-04-15 English
Appendix 4C - Quarterly and Business Update 8 pages 278.1KB
Interim / Quarterly Report
2019-04-15 English
IMU presents new mimotope PD-1 vaccine data at AACR 2 pages 160.0KB
Regulatory Filings
2019-04-02 English
IMU presents positive new HER-Vaxx data at AACR 3 pages 166.9KB
Regulatory Filings
2019-04-01 English
IMU presents new KEY-Vaxx and B-Vaxx data at AACR 3 pages 164.9KB
Regulatory Filings
2019-04-01 English
Investor Presentation 25 pages 1.0MB
Investor Presentation
2019-03-25 English
IMU Pre-IND FDA Meeting Provides Guidance for KEY-Vaxx 2 pages 76.9KB
Regulatory Filings
2019-03-19 English
Imugene doses first patient in HER-Vaxx phase 2 trial 3 pages 97.4KB
Regulatory Filings
2019-03-13 English
IMU Announces Presentations on KEY-Vaxx and B-Vaxx at AACR 3 pages 101.5KB
Regulatory Filings
2019-03-03 English
Imugene Announces Presentation on HER-Vaxx at the AACR 2019 2 pages 85.6KB
Investor Presentation
2019-02-27 English
Pause in Trading 1 page 111.2KB
Regulatory Filings
2019-02-27 English
Half Yearly Report and Accounts 32 pages 4.8MB
Interim / Quarterly Report
2019-02-27 English
Clinical Cancer Research Journal publish B-Vaxx Phase 1 Data 3 pages 91.8KB
Regulatory Filings
2019-02-25 English
Appendix 4C - Quarterly and Business Update 7 pages 572.2KB
Interim / Quarterly Report
2019-01-29 English
Investor Presentation 20 pages 12.4MB
Investor Presentation
2019-01-09 English
IMU appoints distinguished scientist to the Company SAB 3 pages 380.2KB
Board/Management Information
2019-01-06 English